Direkt zum Inhalt
Merck
  • High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease.

High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2013-04-05)
Vasco Meneghini, Valeria Bortolotto, Maria Teresa Francese, Anna Dellarole, Lorenzo Carraro, Slavica Terzieva, Mariagrazia Grilli
ZUSAMMENFASSUNG

Dysregulated hippocampal neurogenesis has been associated with neurodegenerative disorders, including Alzheimer's disease (AD), in which it may potentially represent an auto-reparatory mechanism that could counteract neuronal loss and cognitive impairment. We evaluated hippocampal neurogenesis in TgCRND8 mice and reported that, at 32 weeks of age, corresponding to an advanced AD-like neuropathology stage, increased numbers of proliferating cells, doublecortin-expressing progenitors/neuroblasts, and early postmitotic calretinin-expressing neurons were present compared with wild-type (WT) littermates. When hippocampal neural progenitor cells (NPCs) were isolated from TgCRND8 mice, we demonstrated that (1) their neurogenic potential was higher compared with WT NPCs; (2) medium conditioned by TgCRND8 NPC promoted neuronal differentiation of WT NPCs; and (3) the proneurogenic effect of TgCRND8-conditioned medium was counteracted by blockade of the receptor for advanced glycation end products (RAGE)/nuclear factor-κB (NF-κB) axis. Furthermore, we showed that β-amyloid 1-42 (Aβ(1-42)) oligomers, but not monomers and fibrils, and the alarmin high-mobility group box-1 protein (HMGB-1) could promote neuronal differentiation of NPCs via activation of the RAGE/NF-κB axis. Altogether, these data suggest that, in AD brain, an endogenous proneurogenic response could be potentially triggered and involve signals (Aβ(1-42) oligomers and HMGB-1) and pathways (RAGE/NF-κB activation) that also contribute to neuroinflammation/neurotoxicity. A more detailed analysis confirmed no significant increase of new mature neurons in hippocampi of TgCRND8 compared with WT mice, suggesting reduced survival and/or integration of newborn neurons. Therapeutic strategies in AD should ideally combine the ability of sustaining hippocampal neurogenesis as well as of counteracting an hostile brain microenvironment so to promote survival of vulnerable cell populations, including adult generated neurons.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Milch-Dehydrogenase aus Kaninchenmuskel, Type XI, lyophilized powder, 600-1,200 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Kaninchenmuskel, Type II, ammonium sulfate suspension, 800-1,200 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rinderherz, Type III, ammonium sulfate suspension, ≥500 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rinderherz, 1000 units/mL
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rinderherz, Type XVII, buffered aqueous glycerol solution, ≥400 units/mg protein
Sigma-Aldrich
L-Milch-Dehydrogenase aus Schweineherz, ammonium sulfate suspension, ≥200 units/mg protein
Sigma-Aldrich
L-Lactat-Dehydrogenase, rekombinant aus E. coli, ≥90 U/mg
Sigma-Aldrich
L-Milch-Dehydrogenase aus Rindermuskel, Type X, ammonium sulfate suspension, ≥600 units/mg protein